[Cytostatic chemotherapy in the treatment of malignant tumors].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy; D007970:Leukopenia / Q000139:chemically induced; D008175:Lung Neoplasms / Q000188:drug therapy; D008206:Lymphatic Diseases / Q000188:drug therapy; D008207:Lymphatic Metastasis / Q000188:drug therapy; D008479:Mediastinal Neoplasms / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D011033:Podophyllin / Q000627:therapeutic use; D012004:Rectal Neoplasms / Q000188:drug therapy; D014228:Triaziquone / Q000627:therapeutic use
D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D011033:Podophyllin; D014228:Triaziquone
Zytostatische Chemotherapie in der Malignombehandlung.